Wall St. provides estimates for future stock prices of Eli Lilly from 2025 to 2030 based on projected revenue and net income.

Baron Funds, an investment management company, released its “Baron Fifth Avenue Growth Fund” first quarter 2025 investor ...

Eli Lilly's stock price has over-corrected following a downgrade in its outlook following the adjustment for acquisition ...

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally. The company offers Basaglar, Humalog, Humalog Mix 75/ ...

Although Eli Lilly experienced lower price realization ... From a valuation perspective, we believe LLY stock has significant growth potential. At its current level of under $800, LLY trades ...

Separately, see – What’s Happening With XRP’s Price? Going by what you pay per dollar of sales or profit, LLY stock looks very expensive compared to the broader market. Eli Lilly's Revenues ...

Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.

Analysts arrive at stock ratings after doing extensive ... with a price target of $1100.00 to $1050.00. The current price Eli Lilly (LLY) is trading at is $782.91, which is out of the analyst ...

Eli Lilly (LLY) Stock Price Prediction in 2025 The current Wall Street consensus 1-year price target of Eli Lilly stock is $1030.00, which is 12.39% higher than today’s price of $916.46.